Australia's most trusted
source of pharma news
Friday, 17 April 2026
Friday, 17 April 2026
Subscribe
Login
Bosses crack the $40M Club
Pay for pharma's ultra-successful appears to have shifted north, with a handful of CEOs moving into the rarified AU$40 million-a-year Club. See who made the cut.
No TGA action after patient deaths
ICYMI: Despite 8 overseas deaths and action from the FDA, the TGA is taking a routine approach plus the other popular stories this week
TODAY Your Week in 5 Minutes
Leaders pitch for MA Board role
Nine leaders are hoping to join the Medicines Australia Board with nominees pitching their case to fill four vacancies
TODAY
Nine leaders vie for MA board seats
Voting will soon open to fill four vacancies on Medicines Australia's Board and the first round of campaign statements are here
16 April
Pfizer names local as Interim MD
Internal pick to step up as Interim Managing Director, after the surprise resignation of Anne Harris in January
15 April
Patient fury over pricing standoff
Company accused of "walking away from PBS pricing negotiations" leaving Aussie cancer patients $64K out-of-pocket
15 April
Time for a tough conversation
It's been a whirlwind seven weeks since Ali Rossiter took the top job at Novartis ANZ and now it's time to talk
14 April
Latest Jobs
Senior Medical Science LiaisonInventory Team SupervisorPharmaceutical Sales RepresentativeQA SpecialistSenior Regulatory Affairs AssociateInventory AnalystClinical Trial Start Up SpecialistSenior Data & Insights Analyst28 more...
Pharma in Focus Jobs
Marketing & Communications (4)
- Senior Data & Insights Analyst - Melbourne
- Data & Insights Analyst - Melbourne
- Senior Medical Communications Specialist - Sydney
- Brand Manager - Macquarie Park
Sales & Customer Relations (14)
- Pharmaceutical Sales Representative - Sydney
- Account Manager - Sydney
- Senior Territory Manager - Melbourne
- Customer Service Lead - Frenchs Forest
- Customer Service Representative - East Ryde
- Customer Service Representative - St Leonards
- Customer Service Specialist - Frenchs Forest
- Hospital Specialist Representative - Melbourne
- Commercial Analytics & SFE Specialist - Sydney
- Pharmaceutical Sales Representative - Sunshine Coast
- Customer Service Representative - Canning Vale
- Account Manager - Melbourne
- Accountant - Macquarie Park
- Customer Service Representative - Belrose
Clinical & Medical, R&D (9)
- Senior Medical Science Liaison - Melbourne
- Clinical Trial Start Up Specialist - Melbourne
- Clinical Project Manager - Oncology - Sydney, NSW
- Clinical Trials Investigator - Melbourne
- Senior Manager, Clinical Operations (Japan) - Tokyo, Japan
- Medical Lead - Sydney
- Pharmacovigilance and Medical Information Associate - Sydney
- Senior Medical Communications Specialist - Sydney
- Warehouse & Medical Kit Assistant - Blacktown
Regulatory, Pharmacovigilance & QA (3)
- QA Specialist - Melbourne
- Senior Regulatory Affairs Associate - Sydney
- Pharmacovigilance and Medical Information Associate - Sydney
Executive Roles (1)
Other (9)
- Inventory Team Supervisor - Melbourne
- Inventory Analyst - Sydney
- Warehouse Operator - Melbourne
- Inventory Analyst - Sydney
- Forklift Driver & Warehouse Assistant - Lane Cove
- Commercial Finance Analyst - Belrose
- Senior HR Business Partner - Melbourne
- Senior HRBP - Melbourne
- Corporate Operations Manager - Sydney, NSW
New hurdle for Novartis therapy
Telix is suing to invalidate the patent protecting Pluvicto to open the door to launching its competitor treatment
TODAY
PBS listing delivers for rare cancer
The funding of a second-generation drug has given patients with this rare form of lung cancer another option
TODAY
Hyped drug doubles sales forecast
This drug, recently considered by the PBAC, is living up to the hype overseas, with the company doubling its peak sales projections
16 April
Akesa appoints Country Manager
Melbourne-based pharmaceutical provider expands into Japan, appointing a senior industry executive to lead local operations
16 April
Lightning leadership change
A local CEO has been replaced within hours by a company stalwart, but no reason was given for the 'seamless transition'
15 April
Ray of hope for 'bad juju' biotech
The FDA has thrown a lifeline to an Australian company after the discontinuation of its lead trial smashed its market capitalisation
16 April
Pfizer fights back over patient fury
Confirms that price is a sticking point and calls for more flexible reimbursement approaches and increased PBS spending
15 April
Aussie biotech inks global license
A Sydney-headquartered company is positioning itself to become a player in the $20 billion-a-year epigenetic therapy market
15 April
States roll out needle-free vaccine
Third state jumps on board with funding for a needle-free flu vaccine for kids, but elsewhere it's only available on private script
15 April
Is this Big Pharma up for sale?
A generics giant is about to make a bid for a big pharma according to reports, with other consortiums also with an eye on the prize
14 April
Race for $210B market heats up
Sixteen promising candidates in the pipeline as appetite for next-generation therapies grows
14 April
Aussies snag $3B-plus deal
Regeneron is entering the rapidly growing radiopharmaceutical sector under a new strategic collaboration with an Australian company
14 April
Company must hand over emails
This pharma has been ordered by the Federal Court to hand over certain emails and documents to a rival in an ongoing patent battle
14 April
Much-loved CEO suddenly passes
Save Our Sons Duchenne Foundation has announced the "sudden, devastating" passing of its much-loved CEO, Sandy Kervin
13 April